126 related articles for article (PubMed ID: 9493721)
1. Transrectal ultrasonography in evaluation of chronic rectal complications after radiation therapy for carcinoma of the uterine cervix.
Shiojima K; Mitsuhashi N; Yamakawa M; Sakurai H; Niibe H
Invest Radiol; 1998 Feb; 33(2):74-9. PubMed ID: 9493721
[TBL] [Abstract][Full Text] [Related]
2. Late rectal sequelae following definitive radiation therapy for carcinoma of the uterine cervix: a dosimetric analysis.
Roeske JC; Mundt AJ; Halpern H; Sweeney P; Sutton H; Powers C; Rotmensch J; Waggoner S; Weichselbaum RR
Int J Radiat Oncol Biol Phys; 1997 Jan; 37(2):351-8. PubMed ID: 9069307
[TBL] [Abstract][Full Text] [Related]
3. Unique role of proximal rectal dose in late rectal complications for patients with cervical cancer undergoing high-dose-rate intracavitary brachytherapy.
Cheng JC; Peng LC; Chen YH; Huang DY; Wu JK; Jian JJ
Int J Radiat Oncol Biol Phys; 2003 Nov; 57(4):1010-8. PubMed ID: 14575832
[TBL] [Abstract][Full Text] [Related]
4. Analysis of correlation between rectal complications and rectal dose following high dose rate intracavitary radiotherapy in patients with uterine cervix cancer: in vivo dosimetric analysis.
Shin KH; Huh SJ; Chie EK; Choi DR; Lim DH; Kim MK; Lee KC; Kim DY; Ahn YC
Radiat Med; 1999; 17(4):289-93. PubMed ID: 10510902
[TBL] [Abstract][Full Text] [Related]
5. CT-based 3D dose-volume parameter of the rectum and late rectal complication in patients with cervical cancer treated with high-dose-rate intracavitary brachytherapy.
Kato S; Tran DN; Ohno T; Nakano T; Kiyohara H; Ohkubo Y; Kamada T
J Radiat Res; 2010; 51(2):215-21. PubMed ID: 20339256
[TBL] [Abstract][Full Text] [Related]
6. Radiotherapy doses at special reference points correlate with the outcome of cervical cancer therapy.
Yoshimura R; Hayashi K; Ayukawa F; Toda K; Iwata M; Oota S; Hoshi A; Wakatsuki M; Kurosaki H; Okazaki A; Shibuya H
Brachytherapy; 2008; 7(3):260-6. PubMed ID: 18579445
[TBL] [Abstract][Full Text] [Related]
7. Modeling normal tissue complication probability from repetitive computed tomography scans during fractionated high-dose-rate brachytherapy and external beam radiotherapy of the uterine cervix.
Dale E; Hellebust TP; Skjønsberg A; Høgberg T; Olsen DR
Int J Radiat Oncol Biol Phys; 2000 Jul; 47(4):963-71. PubMed ID: 10863066
[TBL] [Abstract][Full Text] [Related]
8. The prediction of late rectal complications following the treatment of uterine cervical cancer by high-dose-rate brachytherapy.
Chen SW; Liang JA; Yang SN; Liu RT; Lin FJ
Int J Radiat Oncol Biol Phys; 2000 Jul; 47(4):955-61. PubMed ID: 10863065
[TBL] [Abstract][Full Text] [Related]
9. Carcinoma of the uterine cervix. II. Lack of impact of prolongation of overall treatment time on morbidity of radiation therapy.
Perez CA; Grigsby PW; Castro-Vita H; Lockett MA
Int J Radiat Oncol Biol Phys; 1996 Jan; 34(1):3-11. PubMed ID: 12118562
[TBL] [Abstract][Full Text] [Related]
10. High dose rate brachytherapy for carcinoma of the cervix: risk factors for late rectal complications.
Uno T; Itami J; Aruga M; Kotaka K; Fujimoto H; Sato T; Minoura S; Ito H
Int J Radiat Oncol Biol Phys; 1998 Feb; 40(3):615-21. PubMed ID: 9486611
[TBL] [Abstract][Full Text] [Related]
11. Late rectal complications evaluated by computed tomography-based dose calculations in patients with cervical carcinoma undergoing high-dose-rate brachytherapy.
Noda SE; Ohno T; Kato S; Ishii T; Saito O; Wakatsuki M; Tamaki T; Watanabe K; Nakano T; Tsujii H
Int J Radiat Oncol Biol Phys; 2007 Sep; 69(1):118-24. PubMed ID: 17513064
[TBL] [Abstract][Full Text] [Related]
12. Intermediate dose-volume parameters and the development of late rectal toxicity after MRI-guided brachytherapy for locally advanced cervix cancer.
Ujaimi R; Milosevic M; Fyles A; Beiki-Ardakani A; Carlone M; Jiang H; Lindsay P; Xie J; Gerber R; Croke J; Skliarenko J; Levin W; Han K
Brachytherapy; 2017; 16(5):968-975.e2. PubMed ID: 28757404
[TBL] [Abstract][Full Text] [Related]
13. Lateral rectal shielding reduces late rectal morbidity following high dose three-dimensional conformal radiation therapy for clinically localized prostate cancer: further evidence for a significant dose effect.
Lee WR; Hanks GE; Hanlon AL; Schultheiss TE; Hunt MA
Int J Radiat Oncol Biol Phys; 1996 May; 35(2):251-7. PubMed ID: 8635930
[TBL] [Abstract][Full Text] [Related]
14. [The value of transrectal sonography in assessing radiogenic rectal changes].
Schratter-Sehn AU; Miholic J; Kärcher KH; Eilenberger M; Wrba F; Schratter M
Strahlenther Onkol; 1991 May; 167(5):287-91. PubMed ID: 2038712
[TBL] [Abstract][Full Text] [Related]
15. Dose optimization of fractionated external radiation and high-dose-rate intracavitary brachytherapy for FIGO stage IB uterine cervical carcinoma.
Lee SW; Suh CO; Chung EJ; Kim GE
Int J Radiat Oncol Biol Phys; 2002 Apr; 52(5):1338-44. PubMed ID: 11955747
[TBL] [Abstract][Full Text] [Related]
16. Staging of rectal carcinoma with transrectal ultrasonography.
Nesbakken A; Løvig T; Lunde OC; Nygaard K
Scand J Surg; 2003; 92(2):125-9. PubMed ID: 12841552
[TBL] [Abstract][Full Text] [Related]
17. Comparison between in vivo dosimetry and barium contrast technique for prediction of rectal complications in high-dose-rate intracavitary radiotherapy in cervix cancer patients.
Huh SJ; Lim DH; Ahn YC; Lee JE; Kang MK; Shin SS; Shin KH; Kim B; Park W; Han Y
Strahlenther Onkol; 2003 Mar; 179(3):191-6. PubMed ID: 12627263
[TBL] [Abstract][Full Text] [Related]
18. Radiation therapy morbidity in carcinoma of the uterine cervix: dosimetric and clinical correlation.
Perez CA; Grigsby PW; Lockett MA; Chao KS; Williamson J
Int J Radiat Oncol Biol Phys; 1999 Jul; 44(4):855-66. PubMed ID: 10386643
[TBL] [Abstract][Full Text] [Related]
19. High-dose-rate brachytherapy in the treatment of uterine cervix cancer. Analysis of dose effectiveness and late complications.
Ferrigno R; dos Santos Novaes PE; Pellizzon AC; Maia MA; Fogarolli RC; Gentil AC; Salvajoli JV
Int J Radiat Oncol Biol Phys; 2001 Aug; 50(5):1123-35. PubMed ID: 11483321
[TBL] [Abstract][Full Text] [Related]
20. Time course and incidence of late complications in patients treated with radiation therapy for FIGO stage IB carcinoma of the uterine cervix.
Eifel PJ; Levenback C; Wharton JT; Oswald MJ
Int J Radiat Oncol Biol Phys; 1995 Jul; 32(5):1289-300. PubMed ID: 7635768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
